Aclarion, Inc.
ACONW
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.04
FAIR PRICE
$0.05
MARGIN
$0.01
P/E Ratio
N/A
Div. Yield
N/A
ROE
-0.0%
Market Cap
$21203
Small-cap
COMING SOON
Get notified when ACONW's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Brent Ness
COUNTRY
US
HEADQUARTERS
Broomfield
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate ACONW's fair price
Aclarion, Inc.'s fair price of $0.05 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $0.04, ACONW trades 33.3% below its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting ACONW's risk profile.
RELATIVE · 30%
Comparing ACONW's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for ACONW, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for ACONW.
Explore on BuliosFAQ
What is the fair price of ACONW?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Aclarion, Inc. is $0.05. At the current market price of $0.04, ACONW trades 33.3% below its calculated fair value.
Is ACONW overvalued or undervalued?+
Aclarion, Inc. is currently undervalued based on our valuation model. The stock trades at $0.04, which is 33.3% below the fair price of $0.05.
How often is ACONW's fair price updated?+
We update fair price calculations for ACONW daily after market close. The current fair price of $0.05 incorporates the latest market data and sector multiples.
What factors affect ACONW's fair price calculation?+
ACONW's fair price of $0.05 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -0.0%.
Is ACONW a good buy right now?+
At $0.04, ACONW trades 33.3% below our fair value estimate of $0.05. The stock is currently undervalued. ROE stands at -0.0% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does ACONW pay dividends?+
ACONW does not currently pay a dividend.